A cell model that replicates the structure and function of the human intestine has been developed, creating an evaluation platform capable of more accurately predicting adverse effects of new drugs.
SAN DIEGO - VivoSim Labs, Inc. (NASDAQ:VIVS) announced today at the Society of Toxicology meeting that its NAMkind liver and intestine models have been validated for predicting toxicity profiles of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results